Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014–2019: a retrospective health claims analysis.

Background: Respiratory syncytial virus (RSV) is a common cause for severe lower respiratory tract infections (LRTI) in children < 2 years of age in Germany – though little is known about the clinical and economic burden of RSV in children with and without risk factors per month of life. Methods: In...

Full description

Bibliographic Details
Published in:Infection Vol. 53; no. 1; pp. 393 - 405
Main Authors: Lade, Caroline, Bayer, Lea, Huebbe, Bennet, Riedel, Jennifer, Melnik, Sima, Brestrich, Gordon, von Eiff, Christof, Tenenbaum, Tobias
Format: research tables/charts Journal Article
Published: Springer Nature Feb2025
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183079923&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183079923
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03008126
        NXO
      jtl: Infection
      issn: 03008126
      maglogo: N
    pubinfo:
      dt: Feb2025
      vid: 53
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        183079923
        179921669
        183079923
        183079923
        10.1007/s15010-024-02391-x
        183079923
      ppf: 393
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014–2019: a retrospective health claims analysis.
      aug:
        au:
          Lade, Caroline
          Bayer, Lea
          Huebbe, Bennet
          Riedel, Jennifer
          Melnik, Sima
          Brestrich, Gordon
          von Eiff, Christof
          Tenenbaum, Tobias
        affil: https://ror.org/00m8w3m39 Pfizer Pharma GmbH, Berlin, Germany
      sug:
        subj:
          Respiratory Syncytial Virus Infections Epidemiology
          Respiratory Syncytial Virus Infections Mortality
          Respiratory Syncytial Virus Infections Economics
          Economic Aspects of Illness
          Health Resource Utilization
          Health Expenditures
          Human
          Germany
          Male
          Female
          Infant
          Child, Preschool
          Retrospective Design
          Record Review
          Inpatients
          Financial Stress
          Health Care Costs
          Funding Source
          Infant: 1-23 months
          Child, Preschool: 2-5 years
          Male
          Female
      ab: Background: Respiratory syncytial virus (RSV) is a common cause for severe lower respiratory tract infections (LRTI) in children < 2 years of age in Germany – though little is known about the clinical and economic burden of RSV in children with and without risk factors per month of life. Methods: In a retrospective health claims analysis, we identified RSV inpatient cases between 2014 and 2019. We assessed incidence rates, mortality rate, healthcare resource utilization, associated direct costs per case and excess costs for 30, 90 and 365 days after hospital admission matched to a control group. The outcomes are reported separately for the first and second year of life (i.e., for infants and toddlers) and were stratified by month of life, preterm and risk status (i.e., presence of underlying disease: chronic respiratory or cardiac disease, immunosuppression, neurological diseases, diabetes, conditions originating in the perinatal period). Results: RSV-attributable hospital incidence rate was higher in infants (30.25/1,000) than toddlers (14.52/1,000), highest in the first three months of life (44.21/1,000), in infants born preterm (64.76/1,000) or with any underlying disease (54.85/1,000). Mortality rate was also higher for infants (0.08/1,000) than toddlers (0.04/1,000). Mean 30-day excess costs ranged from 2,953 € for infants born full-term at no risk, hospitalized for 5 days, to 6,694 € for infants born extremely premature, hospitalized for 7 days. Conclusion: In Germany, the clinical and economic burden of RSV is substantial, especially in the most vulnerable population, that is, very young infants, those born premature and/or those with an underlying disease.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N